Peripheral Biomarker Candidates of Posttraumatic Stress Disorder

Overview

Journal Exp Neurobiol

Specialty Neurology

Date 2015 Sep 29

PMID 26412967

Citations 7

Authors

Hee Jin Kang

Sujung Yoon

In Kyoon Lyoo

Affiliations

Soon will be listed here.

Abstract

There is high variability in the manifestation of physical and mental health problems following exposure to trauma and disaster. Although most people may show a range of acute symptoms in the aftermath of traumatic events, chronic and persistent mental disorders may not be developed in all individuals who were exposed to traumatic events. The most common long-term pathological consequence after trauma exposure is posttraumatic stress disorder (PTSD). However, comorbid conditions including depression, anxiety disorder, substance use-related problems, and a variety of other symptoms may frequently be observed in individuals with trauma exposure. Post-traumatic syndrome (PTS) is defined collectively as vast psychosocial problems that could be experienced in response to traumatic events. It is important to predict who will continue to suffer from physical and mental health problems and who will recover following trauma exposure. However, given the heterogeneity and variability in symptom manifestations, it is difficult to find identify biomarkers which predict the development of PTSD. In this review, we will summarize the results of recent studies with regard to putative biomarkers of PTSD and suggest future research directions for biomarker discovery for PTSD.

Citing Articles

Abnormal intestinal milieu in posttraumatic stress disorder is not impacted by treatment that improves symptoms.

Voigt R, Zalta A, Raeisi S, Zhang L, Brown J, Forsyth C Am J Physiol Gastrointest Liver Physiol. 2022; 323(2):G61-G70.

PMID: 35638693 PMC: 9291416. DOI: 10.1152/ajpgi.00066.2022.

Current and future functional imaging techniques for post-traumatic stress disorder.

Prasad A, Chaichi A, Kelley D, Francis J, Gartia M RSC Adv. 2022; 9(42):24568-24594.

PMID: 35527877 PMC: 9069787. DOI: 10.1039/c9ra03562a.

Neuroendocrine drivers of risk and resilience: The influence of metabolism & mitochondria.

Turkson S, Kloster A, Hamilton P, Neigh G Front Neuroendocrinol. 2019; 54:100770.

PMID: 31288042 PMC: 6886586. DOI: 10.1016/j.yfrne.2019.100770.

PTSD Biomarker Database: deep dive metadatabase for PTSD biomarkers, visualizations and analysis tools.

Domingo-Fernandez D, Provost A, Tom Kodamullil A, Marin-Llao J, Lasseter H, Diaz K Database (Oxford). 2019; 2019.

PMID: 31260040 PMC: 6601392. DOI: 10.1093/database/baz081.

Polygenic risk associated with post-traumatic stress disorder onset and severity.

Misganaw B, Guffanti G, Lori A, Abu-Amara D, Flory J, Mueller S Transl Psychiatry. 2019; 9(1):165.

PMID: 31175274 PMC: 6555815. DOI: 10.1038/s41398-019-0497-3.

References

Sah R, Ekhator N, Strawn J, Sallee F, Baker D, Horn P . Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder. Biol Psychiatry. 2009; 66(7):705-7. PMC: 4751867. DOI: 10.1016/j.biopsych.2009.04.037. View

Matsuoka Y, Nishi D, Noguchi H, Kim Y, Hashimoto K . Longitudinal changes in serum brain-derived neurotrophic factor in accident survivors with posttraumatic stress disorder. Neuropsychobiology. 2013; 68(1):44-50. DOI: 10.1159/000350950. View

Zhang L, Li H, Hu X, Benedek D, Fullerton C, Forsten R . Mitochondria-focused gene expression profile reveals common pathways and CPT1B dysregulation in both rodent stress model and human subjects with PTSD. Transl Psychiatry. 2015; 5:e580. PMC: 4490278. DOI: 10.1038/tp.2015.65. View

. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001; 69(3):89-95. DOI: 10.1067/mcp.2001.113989. View

Miller M, Sadeh N . Traumatic stress, oxidative stress and post-traumatic stress disorder: neurodegeneration and the accelerated-aging hypothesis. Mol Psychiatry. 2014; 19(11):1156-62. PMC: 4211971. DOI: 10.1038/mp.2014.111. View

Yehuda R, Neylan T, Flory J, McFarlane A . The use of biomarkers in the military: from theory to practice. Psychoneuroendocrinology. 2013; 38(9):1912-22. DOI: 10.1016/j.psyneuen.2013.06.009. View

Kilpatrick D, Koenen K, Ruggiero K, Acierno R, Galea S, Resnick H . The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults. Am J Psychiatry. 2007; 164(11):1693-9. DOI: 10.1176/appi.ajp.2007.06122007. View

Wu G, Feder A, Cohen H, Kim J, Calderon S, Charney D . Understanding resilience. Front Behav Neurosci. 2013; 7:10. PMC: 3573269. DOI: 10.3389/fnbeh.2013.00010. View

Pietrzak R, Sumner J, Aiello A, Uddin M, Neumeister A, Guffanti G . Association of the rs2242446 polymorphism in the norepinephrine transporter gene SLC6A2 and anxious arousal symptoms of posttraumatic stress disorder. J Clin Psychiatry. 2015; 76(4):e537-8. PMC: 4526154. DOI: 10.4088/JCP.14l09346. View

10.

Meewisse M, Reitsma J, Vries G, Gersons B, Olff M . Cortisol and post-traumatic stress disorder in adults: systematic review and meta-analysis. Br J Psychiatry. 2007; 191:387-92. DOI: 10.1192/bjp.bp.106.024877. View

11.

Michopoulos V, Rothbaum A, Corwin E, Bradley B, Ressler K, Jovanovic T . Psychophysiology and posttraumatic stress disorder symptom profile in pregnant African-American women with trauma exposure. Arch Womens Ment Health. 2014; 18(4):639-48. PMC: 4609532. DOI: 10.1007/s00737-014-0467-y. View

12.

Southwick S, Bremner J, Rasmusson A, Morgan 3rd C, Arnsten A, Charney D . Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry. 1999; 46(9):1192-204. DOI: 10.1016/s0006-3223(99)00219-x. View

13.

Glover E, Mercer K, Norrholm S, Davis M, Duncan E, Bradley B . Inhibition of fear is differentially associated with cycling estrogen levels in women. J Psychiatry Neurosci. 2013; 38(5):341-8. PMC: 3756118. DOI: 10.1503/jpn.120129. View

14.

von Kanel R, Abbas C, Begre S, Saner H, Gander M, Schmid J . Posttraumatic stress disorder and soluble cellular adhesion molecules at rest and in response to a trauma-specific interview in patients after myocardial infarction. Psychiatry Res. 2010; 179(3):312-7. DOI: 10.1016/j.psychres.2009.06.005. View

15.

Lehto S, Elomaa A, Niskanen L, Herzig K, Tolmunen T, Viinamaki H . Serum adipokine levels in adults with a history of childhood maltreatment. Prog Neuropsychopharmacol Biol Psychiatry. 2012; 37(2):217-21. DOI: 10.1016/j.pnpbp.2012.01.016. View

16.

Eraly S, Nievergelt C, Maihofer A, Barkauskas D, Biswas N, Agorastos A . Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry. 2014; 71(4):423-31. PMC: 4032578. DOI: 10.1001/jamapsychiatry.2013.4374. View

17.

Baker D, Nievergelt C, OConnor D . Biomarkers of PTSD: neuropeptides and immune signaling. Neuropharmacology. 2011; 62(2):663-73. DOI: 10.1016/j.neuropharm.2011.02.027. View

18.

Tang Y, Li W, Mercer K, Bradley B, Gillespie C, Bonsall R . Genotype-controlled analysis of serum dopamine β-hydroxylase activity in civilian post-traumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2010; 34(8):1396-401. PMC: 2974949. DOI: 10.1016/j.pnpbp.2010.07.002. View

19.

Duman R . Synaptic plasticity and mood disorders. Mol Psychiatry. 2002; 7 Suppl 1:S29-34. DOI: 10.1038/sj.mp.4001016. View

20.

Rasmusson A, Shi L, Duman R . Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock. Neuropsychopharmacology. 2002; 27(2):133-42. DOI: 10.1016/S0893-133X(02)00286-5. View